BioNano Genomics, Inc. (BNGO)
1.16
0.00 (0.00%)
Upcoming Events
Latest Headlines
Bionano reports studies show optical genome mapping detects genetic variants in reproductive health
June 11, 2026 8:04 AM - StreetInsider
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
June 11, 2026 8:00 AM - StreetInsider
Form 8-K Bionano Genomics, Inc. For: Jun 02
June 5, 2026 4:00 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: Jun 03 Filed by: Dixon Jonathan V.
June 3, 2026 8:52 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: Jun 03 Filed by: OLDAKOWSKI MARK
June 3, 2026 8:51 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: Jun 03 Filed by: Chaubey Alka
June 3, 2026 8:51 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: Jun 03 Filed by: Adamchak Mark
June 3, 2026 8:50 PM - SEC Filing
Bionano retires $20 million convertible debt, eliminates secured obligations
May 28, 2026 8:09 AM - StreetInsider
Form 8-K Bionano Genomics, Inc. For: May 28
May 28, 2026 8:00 AM - SEC Filing
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
May 28, 2026 8:00 AM - StreetInsider
Bionano study finds genome mapping detects 97.8% of T-cell leukemia cases
May 26, 2026 8:05 AM - StreetInsider
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
May 26, 2026 8:00 AM - StreetInsider
Form 4 Bionano Genomics, Inc. For: May 14 Filed by: Rajkovic Aleksandar
May 14, 2026 6:17 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: May 14 Filed by: Linney Yvonne
May 14, 2026 6:16 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: May 14 Filed by: Vuori Kristiina MD
May 14, 2026 6:15 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: May 14 Filed by: TWOMEY CHRISTOPHER J
May 14, 2026 6:15 PM - SEC Filing
Form 4 Bionano Genomics, Inc. For: May 14 Filed by: BARKER DAVID L
May 14, 2026 6:15 PM - SEC Filing
Form 8-K Bionano Genomics, Inc. For: May 14
May 14, 2026 4:30 PM - SEC Filing
Form 10-Q Bionano Genomics, Inc. For: Mar 31
May 13, 2026 4:10 PM - SEC Filing
Bionano Reports First Quarter 2026 Results and Provides a Business Update
May 13, 2026 4:05 PM - StreetInsider
Form 8-K Bionano Genomics, Inc. For: May 13
May 13, 2026 4:03 PM - SEC Filing
BioNano Genomics, Inc. (BNGO) files $400M mixed shelf
May 8, 2026 4:09 PM - StreetInsider
Form S-3 Bionano Genomics, Inc.
May 8, 2026 4:03 PM - SEC Filing
Form 8-K Bionano Genomics, Inc. For: May 05
May 6, 2026 4:31 PM - SEC Filing
Bionano names board chairman Al Luderer as interim CEO
May 6, 2026 4:31 PM - StreetInsider
Bionano Announces Leadership Transition
May 6, 2026 4:30 PM - StreetInsider
Bionano reports 56% increase in rare disease publications using optical genome mapping
May 5, 2026 8:04 AM - StreetInsider
Bionano reports 56% increase in rare disease publications using optical genome mapping
May 5, 2026 8:04 AM - StreetInsider
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025
May 5, 2026 8:00 AM - Globe NewsWire
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026
April 29, 2026 4:05 PM - StreetInsider
Bionano Genomics (BNGO) PT Lowered to $6 at H.C. Wainwright
April 13, 2026 6:39 AM - StreetInsider
Form ARS Bionano Genomics, Inc. For: Dec 31
April 2, 2026 4:07 PM - SEC Filing
Form DEFA14A Bionano Genomics, Inc.
April 2, 2026 4:06 PM - SEC Filing
Form DEF 14A Bionano Genomics, Inc. For: Apr 01
April 2, 2026 4:03 PM - SEC Filing
Bionano study shows optical genome mapping outperforms traditional methods
April 2, 2026 8:03 AM - StreetInsider
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
April 2, 2026 8:00 AM - StreetInsider
Form S-8 Bionano Genomics, Inc.
March 25, 2026 4:29 PM - SEC Filing
Form 10-K Bionano Genomics, Inc. For: Dec 31
March 23, 2026 4:09 PM - SEC Filing
Form 8-K Bionano Genomics, Inc. For: Mar 23
March 23, 2026 4:05 PM - SEC Filing
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
March 23, 2026 4:05 PM - StreetInsider
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
March 17, 2026 8:00 AM - StreetInsider
Full Article List
